Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.330
+0.030 (1.30%)
At close: May 6, 2026, 4:00 PM EDT
2.370
+0.040 (1.72%)
After-hours: May 6, 2026, 7:52 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $425.66 million as of May 6, 2026. Its market cap has increased by 298.73% in one year.
Market Cap
425.66M
Enterprise Value
298.14M
1-Year Change
298.73%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $425.66M, a decrease of -83.52%. That is a compound annual growth rate of -49.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 420.18M | 38.13% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 452.15M |
| Vanda Pharmaceuticals | 447.40M |
| Eupraxia Pharmaceuticals | 446.33M |
| Enanta Pharmaceuticals | 442.25M |
| Larimar Therapeutics | 431.11M |
| Benitec Biopharma | 430.93M |
| Monopar Therapeutics | 427.36M |
| PureTech Health | 425.06M |